These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26483878)

  • 21. Contemporary Management of Localized Resectable Pancreatic Cancer.
    Kommalapati A; Tella SH; Goyal G; Ma WW; Mahipal A
    Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29361690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Borderline resectable pancreatic cancer: More than an anatomical concept.
    Petrelli F; Inno A; Barni S; Ghidini A; Labianca R; Falconi M; Reni M; Cascinu S;
    Dig Liver Dis; 2017 Feb; 49(2):223-226. PubMed ID: 27931968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borderline resectable pancreatic cancer.
    Varadhachary GR; Tamm EP; Crane C; Evans DB; Wolff RA
    Curr Treat Options Gastroenterol; 2005 Oct; 8(5):377-84. PubMed ID: 16162303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.
    Palmarocchi MC; Balzarotti Canger RC; Saletti P
    Oncol Lett; 2017 Jun; 13(6):4445-4452. PubMed ID: 28588713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives.
    de Scordilli M; Michelotti A; Zara D; Palmero L; Alberti M; Noto C; Totaro F; Foltran L; Guardascione M; Iacono D; Ongaro E; Fasola G; Puglisi F
    Crit Rev Oncol Hematol; 2023 Jun; 186():104013. PubMed ID: 37116817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized Pancreatic Cancer: Multidisciplinary Management.
    Coveler AL; Herman JM; Simeone DM; Chiorean EG
    Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study.
    Vitolo V; Cobianchi L; Brugnatelli S; Barcellini A; Peloso A; Facoetti A; Vanoli A; Delfanti S; Preda L; Molinelli S; Klersy C; Fossati P; Orecchia R; Valvo F
    BMC Cancer; 2019 Sep; 19(1):922. PubMed ID: 31521134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolving role of radiation in pancreatic cancer.
    Malla M; Fekrmandi F; Malik N; Hatoum H; George S; Goldberg RM; Mukherjee S
    Front Oncol; 2022; 12():1060885. PubMed ID: 36713520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
    Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
    BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant/Perioperative Therapy in Pancreatic and Periampullary Cancer.
    Reilley MJ; Shroff R; Varadhachary GR
    Indian J Surg; 2015 Oct; 77(5):403-8. PubMed ID: 26722204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borderline resectable pancreatic cancer.
    Hackert T; Ulrich A; Büchler MW
    Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative Radiation "Boost" to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report.
    Thomas TO; Small W; Fleming M; Kang S; Hoefer RA
    Front Oncol; 2018; 8():12. PubMed ID: 29629335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of borderline resectable pancreatic adenocarcinoma.
    Jia Y; Wang TJ; Allendorf J; Saif MW
    JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Li S; Ni QX; Yu XJ; Liu L
    Curr Med Chem; 2019; 26(40):7196-7211. PubMed ID: 29651946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
    Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
    Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality management of borderline resectable pancreatic adenocarcinoma.
    Prakash LR; Katz MHG
    Chin Clin Oncol; 2017 Jun; 6(3):27. PubMed ID: 28705004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome following neoadjuvant therapy for resectable and borderline resectable pancreatic cancer compared to upfront surgery: a meta-analysis of comparative studies by intention-to-treat analysis.
    Unno M; Hata T; Motoi F
    Surg Today; 2019 Apr; 49(4):295-299. PubMed ID: 30877550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
    Murphy JE; Wo JY; Ryan DP; Jiang W; Yeap BY; Drapek LC; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Faris JE; Zhu AX; Goyal L; Lillemoe KD; DeLaney TF; Fernández-Del Castillo C; Ferrone CR; Hong TS
    JAMA Oncol; 2018 Jul; 4(7):963-969. PubMed ID: 29800971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of neoadjuvant therapy in pancreatic cancer: a review.
    Russo S; Ammori J; Eads J; Dorth J
    Future Oncol; 2016 Mar; 12(5):669-85. PubMed ID: 26880384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
    Schwarz L; Vernerey D; Bachet JB; Tuech JJ; Portales F; Michel P; Cunha AS
    BMC Cancer; 2018 Jul; 18(1):762. PubMed ID: 30041614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.